➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Colorcon
AstraZeneca
Medtronic

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

GLUCAGEN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Glucagen, and when can generic versions of Glucagen launch?

Glucagen is a drug marketed by Novo Nordisk and is included in one NDA.

The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.

Summary for GLUCAGEN
Drug patent expirations by year for GLUCAGEN
Drug Prices for GLUCAGEN

See drug prices for GLUCAGEN

Recent Clinical Trials for GLUCAGEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Herlev HospitalPhase 4
Technical University of DenmarkPhase 4
Steno Diabetes Center CopenhagenPhase 4

See all GLUCAGEN clinical trials

US Patents and Regulatory Information for GLUCAGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk GLUCAGEN glucagon hydrochloride INJECTABLE;INJECTION 020918-001 Jun 22, 1998 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Colorcon
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.